Ariosa Diagnostics, Inc. v. Sequenom, Inc.
United States Court of Appeals for the Federal Circuit
788 F.3d 1371 (2015)
- Written by Eric Miller, JD
Facts
Dennis Lo and James Wainscoat discovered cell-free fetal DNA (cffDNA) in maternal blood samples that researchers had previously treated as medical waste. Lo and Wainscoat were then able to isolate paternally inherited cffDNA, from which certain fetal characteristics could be determined. Lo and Wainscoat obtained a patent (the ‘540 patent) on the process of amplifying and detecting cffDNA. Sequenom, Inc. (defendant) was licensed to commercialize the invention by selling prenatal tests. Sequenom sent letters to companies that sold similar tests, accusing them of patent infringement. One of those companies, Ariosa Diagnostics, Inc. (Ariosa) (plaintiff), sought a declaratory judgment of noninfringement in federal district court. The court found that the ‘540 patent was invalid on the ground that paternal cffDNA was a naturally occurring phenomenon to which Lo and Wainscott failed to make sufficient inventive additions. Sequenom appealed to the United States Court of Appeals for the Federal Circuit.
Rule of Law
Issue
Holding and Reasoning (Reyna, J.)
What to do next…
Here's why 811,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.